pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Drugs
by stage
  • Marketed
  • Phase 3
  • Phase 2
  • Phase 1
  • Preclinical
browse
  • Most catalysts
  • Recently active
  • All drugs →
  • Companies
  • Patent cliff
Calendar
what
  • Trial readouts
  • PDUFA dates
  • Approvals
  • Earnings
when
  • Upcoming
  • Month grid
  • Recently passed
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
  • Drugs
  • Calendar
  • Companies
Hubs
  • Topics
  • Patent cliff
  • Publications
  • Readouts
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
STAT·Jun 1·1 min read
save

FDA misses self-imposed deadline on electric shock device ban, prompting disability advocates' outcry

Jun 1, 2026·read at STAT ↗RegulatoryNegative

The Food and Drug Administration did not issue a decision by the end of May as it had set for itself on whether to prohibit electrical shock devices used on people with intellectual disabilities and autism.

The agency had previously pursued a ban but a court order forced it to pause the process. The devices, which deliver electric shocks to curb self-injurious behavior, have been described by United Nations officials as a form of torture.

Although the practice has largely fallen out of use in the United States, it continues at the Judge Rotenberg Center in Massachusetts, the only remaining facility that still employs the shocks.

Disability rights groups and former recipients are now warning that without a formal ban the shocks may keep being applied, and they are calling on the FDA to act quickly.

source

This writeup was produced by pharmadog from original reporting by STAT.

Original headline: “As FDA misses deadline on electric shock ban, disability advocates speak out”

read at STAT ↗
1,027 words · retrieved Jun 1
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

topics
Oncology2Psychiatry & CNS2ApprovalHematologyNSCLCPulmonology

related stories

  • Sep 10Platinum-based chemotherapy in childhood causes mutations that age the liverSTAT
  • Jun 2910 clinical trials to watch in the second half of 2026BioPharma Dive
  • May 12Dr Postow on the Timing of Delayed or Re-Emergent irAEs in Melanomaonclive
  • May 12Temple Health’s Fox Chase Cancer Center and Labcorp Collaborate to Test Ultra-Sensitive Blood-Based Assay for Early-Stage Lung Cancer Recurrence Riskonclive
  • May 12EGFR-Mutated NSCLC: Mechanism and Clinical Role of TROP2-Directed ADCsonclive